City

Shenzhen (2)

Beijing (1)

Haikou (1)

Condition

Acute Myeloid Leukemia (2)

NK Cell Lymphoma (2)

T-cell Acute Lymphoblastic Leukemia (2)

T-cell Acute Lymphoblastic Lymphoma (2)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

Shenzhen Geno-Immune Medical Institute (2)

Collaborator

Beijing Jingdu Children's Hospital (1)

The Second Affiliated Hospital of Hainan Medical University (1)

Intervention

cd7-specific car gene-engineered t cells (1)

universal cd7-specific car gene-engineered t cells (1)

Study Documents

Intervention Type

biological (2)

Funder Type

Other (2)

Study Type

Interventional (2)

nk cell lymphoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Beijing, Shenzhen,

Recruiting

T-cell Acute Lymphoblastic Leukemia
+3 more

Universal CD7-specific CAR gene-engineered T cells

Beijing, Beijing, China
+2 more

Aug 17, 2023

T-cell Acute Lymphoblastic Leukemia, T-cell Acute Lymphoblastic Lymphoma, Acute Myeloid Leukemia Trial in Shenzhen (CD7-specific

Recruiting

T-cell Acute Lymphoblastic Leukemia
+3 more

CD7-specific CAR gene-engineered T cells

Shenzhen, Guangdong, China

Shenzhen Geno-immune Medical Institute

Sep 18, 2019